The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients
Clinical trial NCT02327039 · COMPLETED
Trial details
- NCT number
- NCT02327039
- Sponsor
- University of Padova
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-09-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.